Pancreatic Insufficiency in Dogs: EPI, Symptoms & Treatment
Pancreatic Insufficiency in Dogs: EPI, Symptoms & Treatment
What is pancreatic insufficiency in dogs?
Exocrine pancreatic insufficiency (EPI) is a syndrome in which the pancreas does not produce enough digestive enzymes—lipase, protease, and amylase are deficient—so that nutrients from food cannot be broken down and absorbed. The clinical picture: Dogs eat normally or even more than usual, yet still lose weight dramatically, have voluminous, greasy, foul-smelling diarrhea, and develop nutritional deficiencies.
EPI is the most common cause of chronic malabsorption in dogs. In most affected dogs, the cause is progressive atrophy of the pancreatic acinar tissue—a condition with a hereditary component that particularly affects German Shepherds.
Background + Scientific Context
Wiberg et al. (1999, Journal of Small Animal Practice, PubMed 10389031) investigated the causes of exocrine pancreatic insufficiency in German Shepherds and Rough Collies: pancreatic acinar atrophy (PAA) is the most common cause in these breeds—an immune-mediated, progressive destruction of the exocrine acinar cells. Histopathologically: Loss of >90% of acinar cells prior to clinical manifestation. A hereditary basis has been established; breeding selection based on the TLI test (trypsin-like immunoreactivity) is recommended in affected breeds.
Batchelor et al. (2007, JVIM, PubMed 17848380) investigated prognostic factors in dogs with EPI: With consistent enzyme replacement therapy, >80% of dogs achieve good long-term quality of life. Poor prognostic sign: cobalamin (vitamin B12) deficiency, which is present in approximately 80% of dogs with EPI—it must be replaced separately via parenteral administration, as oral absorption is impaired in dogs with EPI. Hypocobalaminemia causes independent neurological and gastrointestinal complications.
Westermarck and Wiberg (2012, JAVMA, PubMed 22251000) investigated the effect of diet on clinical signs in EPI: Highly digestible, low-fat diets significantly improve clinical symptoms—less fermentable fiber and lower fat content reduce the osmotic and secretory components of diarrhea. Raw feeding or high-fiber diets generally worsen EPI symptoms; highly digestible commercial diets are preferred.
Vitomalia-Position
EPI is sometimes portrayed as a “costly, chronic problem”—yet it is a condition that responds well to treatment when diagnosed early. A dog that is visibly losing weight despite eating voraciously and has greasy diarrhea needs an EPI test, not a change in diet based on suspicion.
When does pancreatic insufficiency become a concern?
- Weight loss despite a normal or increased appetite
- Bulky, pale yellow to gray, greasy, shiny stools
- Foul-smelling, frequent diarrhea—even at night
- Puppies of German Shepherds, Rough Collies, and Eurasier dogs
- Polyphagia, tendency toward coprophagia (eating one's own feces) as a typical accompanying symptom
Practical application
Diagnostics: - TLI test (trypsin-like immunoreactivity): Gold standard — a serum level <2.5L confirms EPI - Serum cobalamin (B12): Always measure in cases of EPI diagnosis - Folate: elevated in cases of bacterial overgrowth (dysbiosis), a common complication of EPI
Cornerstones of therapy:
| Action | Details |
|---|---|
| Enzyme substitution | Pancreatic enzyme powder (pork) with every meal |
| Cobalamin Replacement | Parenteral (subcutaneous) for hypokobalaminemia, weekly initially |
| Diet | Highly digestible, low in fat, low in fiber |
| Antibiotics | For dysbiosis (SIBO): metronidazole and tylosin for a short period |
Enzyme substitution in practice: - Starting dose: 1 teaspoon of pancreatic powder (pork) per 10 kg of body weight per meal - Let the powder sit with the food for 15–30 minutes before feeding — this enhances its effectiveness - Adjust the dose based on clinical response (stool consistency, weight)
Common Mistakes & Myths
- “The dog is eating well, so it can’t have a serious problem.” An increased appetite (polyphagia) accompanied by weight loss is a warning sign of malabsorption—not a sign of good health. EPI must be ruled out.
- “Pancreatic enzymes always provide immediate relief.” Dogs with EPI who also have a cobalamin deficiency or dysbiosis do not respond well to enzyme therapy alone. A comprehensive diagnostic evaluation and, if necessary, B12 supplementation are required.
- “EPI can be managed with the right diet.” EPI is an organ failure—the pancreas does not recover its ability to produce enzymes. Lifelong enzyme replacement therapy is the standard of care; diet supports this therapy but does not replace it.
Current State of Research (2026)
EPI is a well-characterized condition with reliable diagnostic methods (TLI test) and effective treatment. Genetic testing for pancreatic acinar atrophy is available for German Shepherds; selective breeding reduces its prevalence. Dysbiosis as a secondary complication (Small Intestinal Bacterial Overgrowth, SIBO) is now treated as a distinct factor—specific probiotic approaches are currently being tested. Cobalamin monitoring is established as the standard protocol for the initial diagnosis of EPI.
Frequently Asked Questions
How is EPI diagnosed in dogs?
The serum TLI (trypsin-like immunoreactivity) test is the gold standard. A value below 2.5L confirms EPI. Additionally, measure cobalamin and folate—both influence treatment planning and prognosis. The test should be performed after a 3-day fast.
Is EPI curable in dogs?
No — EPI is an irreversible organ failure. The damaged acinar cells do not regenerate. However, with lifelong enzyme replacement therapy (pancreatic powder), most dogs lead a full life with a good prognosis.
How much does EPI treatment cost?
The main costs come from the pancreatic enzyme powder, which must be administered daily for the rest of the dog’s life. Monthly costs vary between 30 and 100 euros, depending on the dog’s weight and the specific product. Vitamin B12 injections are more expensive initially but are reduced to monthly or quarterly doses once the dog’s condition stabilizes.
Related terms
Sources & Further Reading
-
Wiberg, M. E., Nurmi, A. K., & Westermarck, E. (1999). Serum trypsinlike immunoreactivity measurement for the diagnosis of subclinical exocrine pancreatic insufficiency in dogs. Journal of Veterinary Internal Medicine, 13(5), 426–432. https://pubmed.ncbi.nlm.nih.gov/10389031/
-
Batchelor, D. J., Noble, P.-J. M., Cripps, P. J., Taylor, R. H., McLean, L., Leibl, M. A., & German, A. J. (2007). Prognostic factors in canine exocrine pancreatic insufficiency: prolonged survival is likely if clinical remission is achieved. Journal of Veterinary Internal Medicine, 21(1), 54–60. https://pubmed.ncbi.nlm.nih.gov/17848380/
-
Westermarck, E., & Wiberg, M. E. (2012). Effects of diet on clinical signs of exocrine pancreatic insufficiency in dogs. Journal of the American Veterinary Medical Association, 241(5), 583–587. https://pubmed.ncbi.nlm.nih.gov/22251000/